InvestorsHub Logo
Followers 13
Posts 641
Boards Moderated 0
Alias Born 01/22/2017

Re: None

Thursday, 05/28/2020 10:22:44 PM

Thursday, May 28, 2020 10:22:44 PM

Post# of 8928
Just buy and hold.

Craig McDonald, M.D., the national principal investigator for the HOPE-2 clinical trial and UC Davis professor and chair of the Department of Physical Medicine and Rehabilitation commented, “I am incredibly pleased with the outcome of the HOPE-2 trial which demonstrated clinically relevant benefits of CAP-1002 which resulted in measurable improvements in upper limb, cardiac and respiratory function. This is the first clinical trial which shows benefit to patients in advanced stages of DMD for which treatment options are limited.”

Stock price being played due to lack of institutional support... Their buying will come soon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CAPR News